Callista Private Equity GmbH (“Callista Private Equity“) announces the acquisition of the entire shares of AST Anlagen Systeme Technik Service GmbH (“AST”) by Callista Holdings GmbH & Co. KG. The company was sold in the course of a structured process by AIR LIQUIDE Medical GmbH (“Seller”), a subsidiary of AIR LIQUIDE S.A., listed at Euronext Paris.
AST is a system supplier of technologically sophisticated solutions in special plant construction for the healthcare sector and industry with a focus on services for medical gas supply technologies. The company is active throughout Germany and supplies hospitals, laboratories and industrial customers.
Within the first months post transaction Callista Private Equity will focus on the carve-out from the group of the Seller and on trimming the company looking ahead for standalone capability in the market. AST will be able to develop freely outside the AIR LIQUIDE Group and aim for growth. This is to be achieved on the one hand by new employees throughout Germany, and on the other hand by suitable acquisitions of further companies in the market.
Marc Zube, Chief Operating Officer at Callista Private Equity, comments on the transaction: “With this add-on acquisition to MainTech Systems GmbH, we are following the path of inorganic growth in one of our portfolio companies for the first time and are pleased to have been awarded the contract as a strategic investor in a sale process”. The AST management continues to be staffed by Mr. Olaf Babel, who will drive the growth strategy forward. The Callista portfolio company MainTech Systems GmbH, located in Obernburg am Main, will also be a supporter in this process, as synergies will arise between the companies, which will help both companies in their growth phase.